Indeed, but the principles and processes that cover what options are available for vaccinations are the same as those that cover every other NIHCE recomended treatment, device or drug, that being best *available* evidence, and "cost-effective". What is not clear is precisely where the balance lies between 'brst for patient', and cost.
Let me give you an example. There is a medication I've been on (unfortunately) for years. My direct, personal experience is that one particular brand is always effective with minimal direct side-effects, but several alternatives have had varied results, despite the active ingredients being, at least in theory, identical.
To put it a tad more graphical, some varients regularly make me puke. The "leading" brand neverchas yet, in some 10 years or more of taking it daily.
If the prescription gives the generic name, some pharmaxists will usually supply the brand I ask for that doesn't make me upchuck. Others will not. You get whichever generic brand is cheapest this month.
So .... I asked my GP to switch from the generic name on the prescription to the specified brand. He did .... but only after looking up the cost differential, the same differential on which pharmacists had refused, and telling me he could because it was "only about 60p".
60p a month, for the benefit of not having a medicine that unnecessarily has me throwing up several times a month.
That's certainly "better", in my estimation, and by the way, all the drugs, including the ones that made me barf, were "approved". And also, for what it's worth, I pay for my prescriptions.
Whether it is applied to MMR or to healthcare generally, that gives you an example of the effect of money on treatment offered.
Suppose the premium hadn't been 60p, but £1? Or £5? Or £50?
I certainly would have laid the first two, and cheerfully, to not puke regularly. The third too if I could afford it. And I'd bet I'd not be alone in that judgement. But I'd been puking regularly before I worked out what eas doing it, and even then, several pharmacists declined to provide the one I know doesn't adversely affect me, and the GP checked the prices first.
Cost-effective, eh? Hmmm.